The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on March 3, 2026

Mar. 3, 2026

Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference

Indeterminate GlobeNewswire

Mar. 3, 2026

Kyverna Therapeutics to Participate in Upcoming March Investor Conferences

Indeterminate GlobeNewswire

Mar. 3, 2026

T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors

Indeterminate GlobeNewswire

Mar. 3, 2026

Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT

Indeterminate GlobeNewswire

Mar. 3, 2026

Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026

Indeterminate GlobeNewswire

Mar. 3, 2026

Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference

Indeterminate GlobeNewswire

Mar. 3, 2026

DEEP SEA MINERALS CORP. SIGNALS INTENT TO PROCEED WITH LICENSE APPLICATION IN ACCORDANCE WITH U.S. NOAA PROCESS

Indeterminate GlobeNewswire

Mar. 3, 2026

Lahontan Mobilizes Second Drill Rig to Santa Fe

Indeterminate GlobeNewswire

Mar. 3, 2026

4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer

Indeterminate GlobeNewswire

Mar. 3, 2026

Sigmatic Sciences Launches SigmaticOS – The Only Complete Lab-in-the-Loop Platform for All Scientists

Indeterminate GlobeNewswire

Mar. 3, 2026

Beacon Therapeutics appoints Ryan Robinson as Chief Financial Officer

Indeterminate GlobeNewswire

Mar. 3, 2026

AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression

Indeterminate GlobeNewswire

Mar. 3, 2026

BingX Launches Zero-Fee Carnival for Spot Trading on Crypto & TradFi Assets

Indeterminate GlobeNewswire

Mar. 3, 2026

Quell Therapeutics Initiates CHILL Phase 1/2 Trial of Novel QEL-005 CAR-Treg Therapy in Refractory Rheumatoid Arthritis and Systemic Sclerosis Following UK CTA Approval

Indeterminate GlobeNewswire

Mar. 3, 2026

Quell Therapeutics Demonstrates Safety, Phenotypic Stability, Durability and Early Efficacy with Phenotype‑Locked™ CAR‑Tregs in LIBERATE Phase 1/2 Liver Transplant Study

Indeterminate GlobeNewswire

Mar. 3, 2026

Ride the XRP Wave at Bitrue With a 70,000 XRP Trading Contest

Indeterminate GlobeNewswire

Mar. 3, 2026

Montis Biosciences Advances First-in-Class Dual-Action C1q Antibody with Strong Preclinical Proof-of-Concept in Neuroinflammatory Diseases

Indeterminate GlobeNewswire

Mar. 3, 2026

Bitget y Obside lanzan plataforma de trading con IA en vivo para copy trading

Indeterminate GlobeNewswire

Mar. 3, 2026

Conclusion d’un partenariat entre Bitget et Obside visant à ouvrir AI Trading Arena au copy trading en direct

Indeterminate GlobeNewswire

Mar. 3, 2026

Bitget ו-Obside משתפות פעולה בהשקת זירת מסחר חיה מבוססת בינה מלאכותית למסחר בהעתקה

Indeterminate GlobeNewswire